ALPS Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-31,316
| Closed | -$3.36M | – | 1047 |
|
|
2023
Q1 | $3.36M | Buy |
31,316
+2,814
| +10% | +$302K | 0.03% | 216 |
|
|
2022
Q4 | $3.14M | Buy |
28,502
+6,205
| +28% | +$683K | 0.03% | 227 |
|
|
2022
Q3 | $1.32M | Sell |
22,297
-954
| -4% | -$56.3K | 0.01% | 385 |
|
|
2022
Q2 | $656K | Sell |
23,251
-16,904
| -42% | -$477K | 0.01% | 538 |
|
|
2022
Q1 | $1.52M | Sell |
40,155
-4,909
| -11% | -$185K | 0.02% | 272 |
|
|
2021
Q4 | $1.78M | Buy |
+45,064
| New | +$1.78M | 0.02% | 301 |
|